Former President Trump Announces All 50 States Join Medicaid Drug Pricing Model

Terre Haute, IN, September 18, 2026 —

Former President Donald Trump has announced that all 50 states have joined the Medicaid drug pricing model. The announcement details the participation of every state in the initiative aimed at influencing prescription drug costs within the Medicaid program.

The Medicaid drug pricing model is an initiative designed to address the cost of prescription drugs for the nation’s largest government health insurance program. Details regarding the specific mechanisms, timelines, or potential impacts of this widespread state participation were not immediately available following the announcement. The exact nature of the model and how each state is participating or is expected to participate remains a subject for further clarification.

As of the announcement, the participation of all 50 states signifies a significant level of consensus or engagement with the model. The specific terms under which each state has joined, and whether this involves new agreements, existing frameworks, or legislative actions, were not provided. Further information concerning the operational aspects and anticipated outcomes of the Medicaid drug pricing model is expected.

The contractor or agency responsible for implementing or overseeing this model was not specified in the announcement. Additionally, the timeline for when these states officially joined or are expected to implement specific aspects of the model was not detailed. The announcement focused solely on the confirmation of all 50 states’ involvement.

This development marks a broad uptake for the Medicaid drug pricing model. Further reporting will seek to detail the specific policies each state will adopt and the projected effects on drug pricing and access for beneficiaries.

Story summarized from the original created by By FATIMA HUSSEIN – Associated Press on www.tribstar.com, see more information here.

Media gallery